Aurobindo Pharma Limited — JV/Acquisition, 28-03-2025: Acquisition

Aurobindo Pharma is set to acquire up to a 26% stake in Swarnaaskshu Solar Power Private Limited, aligning with its strategic move towards sustainable energy. The acquisition, valued pending regulatory approval, aims to bolster Aurobindo's green initiatives while also securing a stable power supply for its operations. The acquisition process is expected to conclude by June 30, 2025, offering potential long-term financial and operational benefits through reduced energy costs and enhanced environmental stewardship. This step illustrates Aurobindo's commitment to both growth in renewable resources and operational efficiency.